Scholarly Index
Evangelos Liberopoulos
National and Kapodistrian University of Athens; 10,032 total citations; 497 total publications; best world rank #96
National and Kapodistrian University of Athens
10,032Total citations
497Total publications
53H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lipoproteins and Cardiovascular Health | Lifetime | 460 | GR 6 | 98.10 |
| Cancer, Lipids, and Metabolism | Lifetime | 791 | GR 8 | 97.26 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 752 | GR 5 | 97.58 |
| Pharmacology and Obesity Treatment | Lifetime | 521 | GR 4 | 94.74 |
| Paraoxonase enzyme and polymorphisms | Lifetime | 96 | GR 3 | 93.42 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 552 | GR 4 | 91.18 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 460 | GR 2 | 74.91 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 174 | GR 2 | 96.20 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 574 | GR 5 | 88.11 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 605 | GR 6 | 88.79 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 389 | GR 14 | 86.31 |